Injectafer Lawsuit Updates
Side effects of the iron deficiency drug Injectafer may result in severely low phosphorous levels, which could result in serious and potentially life-threatening injuries. Injectafer lawsuits are being pursued against the drug makers, for failing to adequately warn users and the medical community.
INJECTAFER LAWSUIT CRITERIA: Free consultations and case evaluations are being provided by Injectafer lawyers to determine whether financial compensation or settlements may be available for individuals who have developed a condition known as severe hypophosphatemia (HPP).
This Injectafer side effect may result in:
- Cardiac arrest
- Respiratory failure
- Muscle weakness
CONTACT AN INJECTAFER LAWYER
Find out if you or a loved one may be eligible for an Injectafer settlement. Lawyers review cases on a contingency fee basis, which means there are no fees or expenses unless you win.
Latest Injectafer Lawsuit Updates 2023
February 2023 Update: While final pretrial motions are being considered by the Court for the June 2023 Injectafer trial, two other bellwether claims are now scheduled (PDF) to go before juries on October 2, 2023 and November 29, 2023.
September 2022 Update: U.S. District Judge Wendy Beetlestone has scheduled the first Injectafer trial to begin on June 5, 2023. While the outcome will not be binding on other lawsuits, it may have a big impact on any Injectafer settlement negotiations to avoid the need for each case to go to trial.
August 2021 Update: With dozens of Injectafer lawsuits moving forward in the Eastern District of Pennsylvania, each involving similar allegations that the drug maker failed to warn about side effects of the iron infusion, a motion was filed to consolidate two cases for trial to conserve judicial resources and better gauge how juries will respond to certain evidence and testimony that will be repeated throughout the litigation. However, the Court has determined that the first two Injectafer bellwether cases will go to trial separately.
August 2019 Update: In a study published this month supported the allegations raised in a growing number of lawsuits, indicating that Injectafer side effects can cause hypophosphatemia (HPP), involving dangerously low phosphorus levels.
Learn More About
Side effects of the iron deficiency drug Injectafer may result in severely low phosphorous levels.SEE IF YOU QUALIFY FOR COMPENSATION
Injectafer Litigation Overview
MANUFACTURER: American Regent, a subsidiary of Daiichi Sankyo.
OVERVIEW: Injectafer (ferric carboxymaltose) is an iron infusion delivered through an intravenous injection for adults with anemia, for whom oral iron supplements can not be used and who have non-dialysis dependent chronic kidney disease.
Originally created by Vifor Pharmaceuticals, the Injectafer injection was approved for use in the United States in 2013 and marketed by Luitpold Pharmaceuticals, which then merged with Daiichi Sankyo subsidiary, American Regent.
While the medication was sold as a safe and effective treatment, increasing evidence suggests that the drug makers knew about serious Injectafer side effects and withheld information from users, doctors and regulators as part of a scheme to place profits before patient safety.
INJECTAFER SEVERE HPP RISKS: Studies dating back years have suggested potential Injectafer problems may include the potential to dangerously lower blood phosphorous levels. In fact, the original new drug application for Injectafer was rejected by the FDA in 2006, indicating that “clinically important hypophosphatemia” was one of the safety concerns by FDA reviewers.
In 2015, a study published in the International Journal of Rheumatology warned that 13% of patients receiving Injectafer developed severe and prolonged hypophosphatemia.
According to another study published in PLoS One in December 2016, a “high risk” of developing severe and prolonged HPP was linked to use of Ferinject, which is a brand name for the drug sold outside the U.S., containing the same active ingredient as Injectafer.
More recently, a July 2019 study in Alimentary Pharmacology and Therapeutics found high rates of severe and persistent HPP in patients with inflammatory bowel disease given Injectafer.
HPP is a disturbance of the body’s electrolytes caused by low levels of phosphate in the blood. Some research has suggested that FCM increases the production of fibroblast growth factor 23 hormones in the body. Increases of this hormone are known to cause HPP.
In February 2020, an update was made to the Injectafer FDA label about the hypophosphatemia risk. However, this information remains inadequate and fails to properly disclose the serious risks that users may face, and the importance of monitoring blood phosphate levels after the iron injection.
Find Out If You Qualify for an Injectafer Settlement
As a result of the drug makers’ failure to adequately warn about the risks associated with their medication, Injectafer lawyers are evaluating whether users may be entitled to compensation through a product liability lawsuit or class action lawsuit.
According to allegations presented in the claims, Daiichi Sankyo and it’s American Regent ahd Luitpold Pharmaceuticals subsidiaries withheld important safety information about the HPP risks from Injectafer, and provided false and misleading label warnings and information about Injectafer’s safety for years.
To request a free consultation and claim evaluation to determine whether you, a friend or family member may be entitled to financial compensation through a lawsuit, submit information for review to an Injectafer injury lawyer.
Top Injectafer Articles
Injectafer Long-Term Side Effects Resulted in Fatigue, Pain, Fractures and Other Complications From “Critically Low” Blood Phosphate Levels(10/3/22)
Lawsuit Alleges Injectafer Caused Phosphate Levels To Drop To Critically Low After Iron Infusion(7/13/22)
Injectafer Iron Infusions Require Monitoring of Patient Phosphate Levels, New Case Report Warns(11/22/21)
PaulAugust 23, 2023 at 6:30 am
I had 2 infusions with no side effects and my RKS symptoms were gone for 4 years. Best wishes to anyone with different results.
PatriciaAugust 21, 2022 at 12:26 pm
my heart has been affected after taking this medication but was not warn of side effect, after i look up he medication , then i knew i was affected, please help
MichelleNovember 17, 2020 at 5:02 am
I have been severely ill following my iron infusions
"*" indicates required fields
More Top Stories
A new report highlights how many women and families feel left out of Camp Lejeune settlement negotiations after suffering repeated miscarriages they say were caused by miscarriages on the North Carolina military base.
A Bard Infuse-A-Port lawsuit claims a piece of a failed port catheter broke off, causing a woman to suffer a pulmonary embolism which has resulted in fragments of the device remaining in her heart.
A Wegovy gastroparesis lawsuit blames the weight loss drug for a stomach paralysis problems which left a woman with permanent injuries.